Apogee Reports Strong Q1 Earnings Turnaround, Reaffirms FY27 Guidance, and Announces $9.7M Share Repurchase
Summary
Apogee Enterprises reported a strong Q1 fiscal 2027, turning a prior-year loss into a profit, reaffirmed its full-year guidance, and announced $9.7 million in share repurchases, alongside an update on the Kalwall acquisition.
Key Events
-
Strong Q1 Fiscal 2027 Results
Net earnings significantly improved to $11.5 million ($0.54 diluted EPS) from a loss of $2.7 million (loss of $0.13 diluted EPS) in the prior year, despite a slight 1.1% decrease in net sales.
-
Reaffirmed Fiscal 2027 Guidance
The company reaffirmed its full-year net sales guidance of $1.38 billion to $1.43 billion and adjusted diluted EPS guidance of $2.70 to $3.25, excluding the Kalwall acquisition.
-
Kalwall Acquisition Update
The pending Kalwall acquisition is on track for an early July close. With the acquisition, the company expects fiscal 2027 net sales to be $1.43 billion to $1.48 billion, but the adjusted diluted EPS outlook remains unchanged.
-
Significant Share Repurchases
Apogee returned $15.3 million to shareholders, including $9.7 million in share repurchases and $5.6 million in dividends.
Analysis
This filing details Apogee's first-quarter fiscal 2027 financial results, showing a significant turnaround in profitability with net earnings of $11.5 million compared to a loss in the prior year, driven by improved operating income. The company also reaffirmed its full-year guidance, providing stability and clarity for investors. A notable capital allocation decision was the $9.7 million in share repurchases, demonstrating management's confidence and commitment to returning value to shareholders. The update on the Kalwall acquisition, confirming its early July closing and its expected impact on sales (but not materially on FY27 EPS), provides important context for a previously announced strategic move.
At the time of this filing, APOG was trading at $46.21 on NASDAQ in the Manufacturing sector, with a market capitalization of approximately $907M. The 52-week trading range was $30.75 to $49.99. This filing was assessed with positive market sentiment and an importance score of 8 out of 10.